AGN 1.11% 89.0¢ argenica therapeutics limited

Ann: First Patient Dosed in Phase 2 Stroke Trial of ARG-007, page-18

  1. 1,183 Posts.
    lightbulb Created with Sketch. 121
    I expect there will be carpetbaggers with "sophisticated investors" in tow offering their services. We do appear to have a great board and relatively tight register hopefully they do hold tight until the results of this phase is known.

    Looks like whoever was trying to shake out shares over the last month or so has decided they need to up their entry point.
 
watchlist Created with Sketch. Add AGN (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.